康拓紅外(300455.SZ):董事長趙大鵬辭職 邵文峯暫代履職
格隆匯3月30日丨康拓紅外(300455.SZ)公佈,公司董事會於近日收到公司董事長趙大鵬,董事李虎和董事孫宏偉的書面辭職報告,趙大鵬因工作原因申請辭去公司第三屆董事會董事長、董事以及董事會戰略委員會主任委員職務。
李虎因工作原因申請辭去公司第三屆董事會董事、董事會戰略委員會委員以及董事會薪酬與考核委員會委員職務。孫宏偉因工作原因申請辭去公司第三屆董事會董事和董事會審計委員會委員職務。辭去上述職務後,趙大鵬、李虎和孫宏偉在公司無任職。
在新任董事長選舉產生之前,根據《北京康拓紅外技術股份有限公司章程》規定,半數以上董事共同推舉邵文峯代為履行董事長職務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.